NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

Clinical trial NCT07211737 · RECRUITING

Trial details

NCT number: NCT07211737
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Neuroblastoma Refractory Neuroblastoma Relapsed Osteosarcoma Refractory Osteosarcoma

Start date: 2026-07-15
Primary completion: 2029-04-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.